In keeping with these data, tumor-associated neovascularization (evaluated using a microvessel density assessment) was significantly reduced in suppressed tumors from ACTIBIND-treated mice compared to control animals, and the antiangiogenic effect of ACTIBIND was coupled to a marked increase in apoptosis and a significant reduction in MMP-2 expression within the tumor mass. Here, MMP2 is linked to neoplasm.